Home > News > Nanoparticles May Detect Alzheimer's, Reversal Of Memory Loss
September 18th, 2003
Nanoparticles May Detect Alzheimer's, Reversal Of Memory Loss
Researchers have discovered for the first time in humans the presence of neurotoxic peptide assemblies that may be responsible for the memory loss found in individuals suffering from Alzheimer's disease (AD). The next step is to develop clinical diagnostics -- using nanoparticles -- to detect the amyloid beta-derived diffusible ligands (ADDLs), and effective drugs that prevent the onset of AD, delay its progression, and potentially restore cognitive function in patients with memory-related disorders, as reported in NanoBiotech News.
New non-invasive method can detect Alzheimer's disease early: MRI probe technology shows brain toxins in living animals for first time December 22nd, 2014
Enzyme Biosensor Used for Rapid Measurement of Drug December 22nd, 2014
Creation of 'Rocker' protein opens way for new smart molecules in medicine, other fields December 18th, 2014
Iranian Researchers Produce Electrical Pieces Usable in Human Body December 18th, 2014